An institutional investor in MedImmune has sent a third letter to the firm's board pushing for a sale of the company, saying that negative Wall Street reaction to recent quarterly earnings "must be viewed as a total rejection of the management's strategy." -
MedImmune Investor Makes Third Plea for Sell-Off
An institutional investor in MedImmune has sent a third letter to the firm's board pushing for a sale of the company, saying that negative Wall Street reaction to recent quarterly earnings "must be viewed as a total rejection of the management's strategy."-
By Michael S. Rosenwald